| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 5.79e-07 | 17 | 20 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 9.69e-05 | 1180 | 20 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 1.69e-04 | 1289 | 20 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 7.50e-04 | 758 | 20 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 9.19e-04 | 793 | 20 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | channel activity | 1.64e-03 | 525 | 20 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.65e-03 | 526 | 20 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.05e-03 | 296 | 20 | 3 | GO:0015291 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.09e-03 | 83 | 20 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.12e-03 | 627 | 20 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.84e-03 | 664 | 20 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.24e-03 | 119 | 20 | 2 | GO:0015294 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.86e-03 | 125 | 20 | 2 | GO:0015108 | |
| GeneOntologyMolecularFunction | symporter activity | 9.75e-03 | 150 | 20 | 2 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 9.87e-03 | 151 | 20 | 2 | GO:0008509 | |
| GeneOntologyMolecularFunction | heme binding | 1.03e-02 | 154 | 20 | 2 | GO:0020037 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.03e-02 | 459 | 20 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.14e-02 | 477 | 20 | 3 | GO:0022804 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.16e-02 | 164 | 20 | 2 | GO:0046906 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.20e-02 | 167 | 20 | 2 | GO:0015079 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.25e-02 | 171 | 20 | 2 | GO:0015103 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.50e-02 | 188 | 20 | 2 | GO:0015078 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.86e-02 | 211 | 20 | 2 | GO:0016758 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 2.35e-02 | 239 | 20 | 2 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.63e-02 | 254 | 20 | 2 | GO:0043177 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 4.67e-08 | 9 | 18 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 3.10e-07 | 16 | 18 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 3.77e-07 | 17 | 18 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 3.77e-07 | 17 | 18 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 4.52e-07 | 18 | 18 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 8.51e-07 | 22 | 18 | 3 | GO:0071360 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 9.78e-07 | 23 | 18 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.27e-06 | 25 | 18 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 1.27e-06 | 25 | 18 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 1.80e-06 | 28 | 18 | 3 | GO:0071359 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 1.80e-06 | 28 | 18 | 3 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 1.80e-06 | 28 | 18 | 3 | GO:0002839 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 2.72e-06 | 32 | 18 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 3.59e-06 | 35 | 18 | 3 | GO:0032816 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 5.40e-06 | 40 | 18 | 3 | GO:0045954 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 5.83e-06 | 41 | 18 | 3 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 6.27e-06 | 42 | 18 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 6.27e-06 | 42 | 18 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 7.23e-06 | 44 | 18 | 3 | GO:0002717 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.00e-05 | 49 | 18 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.07e-05 | 50 | 18 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.27e-05 | 53 | 18 | 3 | GO:0001914 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.42e-05 | 55 | 18 | 3 | GO:0043330 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.50e-05 | 56 | 18 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 1.95e-05 | 61 | 18 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.14e-05 | 63 | 18 | 3 | GO:0043331 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 2.36e-05 | 65 | 18 | 3 | GO:0045429 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 2.58e-05 | 67 | 18 | 3 | GO:1904407 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 2.95e-05 | 70 | 18 | 3 | GO:0001913 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 3.07e-05 | 71 | 18 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.48e-05 | 74 | 18 | 3 | GO:0002711 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 3.77e-05 | 76 | 18 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 3.77e-05 | 76 | 18 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 4.23e-05 | 79 | 18 | 3 | GO:0001912 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 4.40e-05 | 80 | 18 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 4.56e-05 | 81 | 18 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 5.85e-05 | 88 | 18 | 3 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 7.82e-05 | 97 | 18 | 3 | GO:0045428 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 8.56e-05 | 100 | 18 | 3 | GO:0080164 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon production | 9.34e-05 | 103 | 18 | 3 | GO:0032729 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 9.49e-05 | 1374 | 18 | 7 | GO:0006811 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 9.89e-05 | 105 | 18 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.11e-04 | 109 | 18 | 3 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 1.17e-04 | 111 | 18 | 3 | GO:0002709 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 1.20e-04 | 112 | 18 | 3 | GO:0006809 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 1.51e-04 | 121 | 18 | 3 | GO:0046209 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.58e-04 | 1017 | 18 | 6 | GO:0098660 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 1.58e-04 | 123 | 18 | 3 | GO:2001057 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.62e-04 | 124 | 18 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.62e-04 | 124 | 18 | 3 | GO:0030101 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 2.27e-04 | 139 | 18 | 3 | GO:0019882 | |
| GeneOntologyBiologicalProcess | macrophage activation | 2.32e-04 | 140 | 18 | 3 | GO:0042116 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 2.60e-04 | 1115 | 18 | 6 | GO:0034220 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 2.68e-04 | 147 | 18 | 3 | GO:0031341 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.84e-04 | 150 | 18 | 3 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 2.84e-04 | 150 | 18 | 3 | GO:0002708 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 3.13e-04 | 155 | 18 | 3 | GO:0032649 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 3.37e-04 | 159 | 18 | 3 | GO:0002821 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 3.62e-04 | 163 | 18 | 3 | GO:0002456 | |
| GeneOntologyBiologicalProcess | type II interferon production | 4.03e-04 | 169 | 18 | 3 | GO:0032609 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 4.46e-04 | 175 | 18 | 3 | GO:0002705 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 5.41e-04 | 187 | 18 | 3 | GO:0001909 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 9.29e-04 | 922 | 18 | 5 | GO:0098662 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.01e-03 | 232 | 18 | 3 | GO:0002706 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 1.02e-03 | 942 | 18 | 5 | GO:0098655 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.05e-03 | 235 | 18 | 3 | GO:0002822 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.28e-03 | 252 | 18 | 3 | GO:0002819 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | 1.44e-03 | 586 | 18 | 4 | GO:0001819 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.65e-03 | 1048 | 18 | 5 | GO:0014070 | |
| GeneOntologyBiologicalProcess | cell killing | 2.26e-03 | 307 | 18 | 3 | GO:0001906 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 2.30e-03 | 309 | 18 | 3 | GO:0002703 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 2.47e-03 | 317 | 18 | 3 | GO:0002699 | |
| GeneOntologyBiologicalProcess | cellular response to lipopolysaccharide | 2.49e-03 | 318 | 18 | 3 | GO:0071222 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 2.54e-03 | 320 | 18 | 3 | GO:0002274 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 2.55e-03 | 1157 | 18 | 5 | GO:0006812 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 2.81e-03 | 91 | 18 | 2 | GO:0140115 | |
| GeneOntologyBiologicalProcess | cellular response to molecule of bacterial origin | 2.82e-03 | 332 | 18 | 3 | GO:0071219 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 3.65e-03 | 364 | 18 | 3 | GO:0071216 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 4.22e-03 | 112 | 18 | 2 | GO:1902476 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 4.28e-03 | 385 | 18 | 3 | GO:0051251 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 4.92e-03 | 405 | 18 | 3 | GO:0042742 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.01e-03 | 1293 | 20 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.04e-03 | 1299 | 20 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.16e-03 | 1327 | 20 | 6 | GO:0042175 | |
| Domain | IG_MHC | 3.60e-07 | 60 | 19 | 4 | PS00290 | |
| Domain | MHC_I_a_a1/a2 | 1.17e-06 | 21 | 19 | 3 | IPR001039 | |
| Domain | MHC_I | 1.17e-06 | 21 | 19 | 3 | PF00129 | |
| Domain | - | 1.78e-06 | 24 | 19 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.78e-06 | 24 | 19 | 3 | IPR011161 | |
| Domain | MHC_I/II-like_Ag-recog | 7.36e-06 | 38 | 19 | 3 | IPR011162 | |
| Domain | Ig/MHC_CS | 2.66e-05 | 58 | 19 | 3 | IPR003006 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 9.60e-05 | 93 | 14 | 3 | M26985 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 3.02e-04 | 137 | 14 | 3 | M5669 | |
| Pubmed | 1.63e-10 | 3 | 20 | 3 | 25212604 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 19081632 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 12756263 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 8882725 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 6.50e-10 | 4 | 20 | 3 | 20166740 | |
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 12421908 | ||
| Pubmed | 1.62e-09 | 5 | 20 | 3 | 8982867 | ||
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 1.62e-09 | 5 | 20 | 3 | 24572784 | |
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 3.25e-09 | 6 | 20 | 3 | 19688209 | |
| Pubmed | Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. | 3.25e-09 | 6 | 20 | 3 | 11825567 | |
| Pubmed | 3.25e-09 | 6 | 20 | 3 | 20976056 | ||
| Pubmed | 3.25e-09 | 6 | 20 | 3 | 20219610 | ||
| Pubmed | 3.25e-09 | 6 | 20 | 3 | 10894171 | ||
| Pubmed | Ligands for murine NKG2D display heterogeneous binding behavior. | 3.25e-09 | 6 | 20 | 3 | 11857333 | |
| Pubmed | 5.68e-09 | 7 | 20 | 3 | 25583577 | ||
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 5.68e-09 | 7 | 20 | 3 | 16831899 | |
| Pubmed | 5.68e-09 | 7 | 20 | 3 | 20870941 | ||
| Pubmed | 5.68e-09 | 7 | 20 | 3 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 5.68e-09 | 7 | 20 | 3 | 30787931 | |
| Pubmed | 5.68e-09 | 7 | 20 | 3 | 12370332 | ||
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 9.09e-09 | 8 | 20 | 3 | 12645935 | |
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 1.36e-08 | 9 | 20 | 3 | 23136011 | |
| Pubmed | Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. | 1.36e-08 | 9 | 20 | 3 | 14764662 | |
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 1.95e-08 | 10 | 20 | 3 | 11827464 | |
| Pubmed | Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. | 2.68e-08 | 11 | 20 | 3 | 26656785 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 19424970 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 19658097 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 28559451 | ||
| Pubmed | 1.74e-04 | 34 | 20 | 2 | 26378152 | ||
| Pubmed | 1.76e-04 | 192 | 20 | 3 | 20602615 | ||
| Pubmed | 2.80e-04 | 43 | 20 | 2 | 21116278 | ||
| Interaction | OR10S1 interactions | 2.35e-05 | 8 | 19 | 2 | int:OR10S1 | |
| Interaction | RAET1L interactions | 6.53e-05 | 13 | 19 | 2 | int:RAET1L | |
| Interaction | OR2G6 interactions | 1.28e-04 | 18 | 19 | 2 | int:OR2G6 | |
| Interaction | TTYH1 interactions | 1.56e-04 | 300 | 19 | 4 | int:TTYH1 | |
| Interaction | ULBP2 interactions | 2.91e-04 | 27 | 19 | 2 | int:ULBP2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 4.88e-05 | 164 | 20 | 3 | chr6q25 | |
| Cytoband | 16p13.3 | 5.02e-03 | 244 | 20 | 2 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 9.78e-03 | 345 | 20 | 2 | chr11q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.46e-02 | 426 | 20 | 2 | chr16p13 | |
| GeneFamily | Solute carriers | 1.37e-04 | 395 | 13 | 4 | 752 | |
| Disease | level of UL16-binding protein 6 in blood serum | 4.36e-07 | 2 | 20 | 2 | OBA_2043185 | |
| Disease | hexanoylcarnitine measurement | 2.87e-05 | 12 | 20 | 2 | EFO_0021040 | |
| Disease | carnitine measurement | 1.21e-03 | 76 | 20 | 2 | EFO_0010469 | |
| Disease | leprosy | 2.20e-03 | 103 | 20 | 2 | EFO_0001054 | |
| Disease | fibrinogen measurement | 2.46e-03 | 109 | 20 | 2 | EFO_0004623 | |
| Disease | keratinocyte carcinoma | 2.87e-03 | 118 | 20 | 2 | EFO_0010176 | |
| Disease | Cardiomyopathies | 3.47e-03 | 130 | 20 | 2 | C0878544 | |
| Disease | glycine measurement | 3.85e-03 | 137 | 20 | 2 | EFO_0009767 | |
| Disease | fibrinogen measurement, coronary artery disease | 4.83e-03 | 154 | 20 | 2 | EFO_0001645, EFO_0004623 | |
| Disease | epilepsy (implicated_via_orthology) | 5.40e-03 | 163 | 20 | 2 | DOID:1826 (implicated_via_orthology) | |
| Disease | metabolite measurement | 6.09e-03 | 560 | 20 | 3 | EFO_0004725 | |
| Disease | basal cell carcinoma | 7.19e-03 | 189 | 20 | 2 | EFO_0004193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLLLALLILVCLCCL | 461 | Q9NX77 | |
| LLILVCLCCLLLVCR | 466 | Q9NX77 | |
| MAASCLVLLALCLLL | 1 | Q9BT22 | |
| LLLLLMFICSSSCIR | 376 | Q96PH1 | |
| MVLLLCLSCLIFSCL | 1 | O00763 | |
| ILISTLLCLIFTCIC | 201 | Q6UVM3 | |
| LSLMLICTLLEFCLA | 186 | Q9H2W1 | |
| CTDVLCCMIFLLCII | 36 | Q8NCS7 | |
| MDSLVVLVLCLSCLL | 1 | P11712 | |
| MRCPKCLLCLSALLT | 1 | Q7Z7M8 | |
| CLILICLLLICIIVM | 36 | P26678 | |
| MALLLCLVCLTAALA | 1 | Q1ZYL8 | |
| CCTLICIICILLLPE | 606 | A1A5C7 | |
| LDLSIRLVMVCLTCL | 381 | Q495M3 | |
| VMALLCICLCLIFFL | 446 | O15389 | |
| LQALLIVLICCCCTL | 151 | Q9UP95 | |
| MRLSVCLLLLTLALC | 1 | O95968 | |
| MLCSLLLCECLLLVA | 1 | Q96S66 | |
| ATTLILCCLLIMCLL | 226 | Q6H3X3 | |
| LCCLLIMCLLICSRH | 231 | Q6H3X3 | |
| ATTLILCCLLIILPC | 226 | Q5VY80 | |
| ATTLILCCLLIILPC | 226 | Q9BZM5 |